Beiersdorf Shares Under Pressure as Analysts Voice Concerns

Beiersdorf shares plummet to 2016 levels after Morgan Stanley and Jefferies issue critical reports, questioning Nivea's recovery and margin targets.

Two prominent financial research firms have simultaneously issued critical assessments of the consumer goods group Beiersdorf. The combined skepticism has pushed the already struggling stock to new lows, with one analyst questioning management's targets and another highlighting fundamental issues at its core Nivea brand.

Stock Plummets to Multi-Year Low

The immediate market reaction was severe. During Monday's trading session, Beiersdorf's shares briefly found themselves at the bottom of the DAX performance table, ultimately closing at €76.62. This price represents a precise new 52-week low, returning the stock to a level not seen since 2016. The recent trend underscores a period of sustained weakness: the share price has shed more than 27% of its value in just the last 30 days. At its current valuation, the DAX-listed equity is now trading directly at the level of a newly issued price target from one of the critical firms. In the absence of fresh fundamental catalysts or visible operational progress on profitability, technical drivers for a sustained recovery appear lacking in the near term.

Morgan Stanley Highlights Core Brand Challenges

The more bearish of the two notes came from Morgan Stanley. Analyst Tilly Eno downgraded the stock to "Underweight" and made a drastic cut to her price target, slashing it from €84 to €77. She cited persistent challenges at the Nivea brand as the primary reason, noting that resolving them would be extremely complex. Eno argued that at the current valuation, the risks facing the company outweigh its potential opportunities. She also pointed to the difficult macroeconomic environment for the entire sector as a weight on investor sentiment.

Jefferies Questions Margin Guidance

Initiating the dual critique, Jefferies analyst David Hayes maintained a "Hold" rating on Beiersdorf but reduced his price target from €92 to €88. Hayes expressed clear doubts about the company's ability to deliver on its optimistic margin outlook presented by management, highlighting a discrepancy between those forecasts and the practical execution on the ground.

This one-two punch from analysts has sent the beleaguered stock deeper into negative territory, reflecting growing market apprehension about the company's near-term prospects.